ELIZABETH WHITE: Open Payments
NPI 1184668584 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 48 payments from 13 companies in 2025. Trend: 2023 $1,572 · 2024 $1,322 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $167 |
| Insulet Corporation | 2 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| Novo Nordisk Inc | 5 | $95 |
| Lilly USA, LLC | 5 | $93 |
| ABBVIE INC. | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $59 |
| Abbott Laboratories | 3 | $54 |
| Ascendis Pharma Endocrinology Inc | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
Products named: Omnipod, Kerendia, MOUNJARO, TEPEZZA, UBRELVY, EVENITY, JARDIANCE, Ozempic.
Industry payments across MS — which companies pay providers there.
